CLSI M100
Performance Standards for Antimicrobial Susceptibility Testing
| Organization: | CLSI |
| Publication Date: | 1 March 2021 |
| Status: | active |
| Page Count: | 352 |
scope:
Abstract
The data in the tables are valid only if the methodologies in CLSI documents M02,1 M07,2 and M113 are followed. These standards contain information about disk diffusion (M021) and dilution (M072 and M113) test procedures for aerobic and anaerobic bacteria. Clinicians depend heavily on information from the microbiology laboratory for treating their seriously ill patients. The clinical importance of antimicrobial susceptibility test results demands that these tests be performed under optimal conditions and that laboratories have the capability to provide results for the newest antimicrobial agents. The tables presented in M100 represent the most current information for drug selection, interpretation, and quality control using the procedures standardized in M02,1 M07,2 and M11.3 Users should replace previously published tables with these new tables. Changes in the tables since the previous edition appear in boldface type.
Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 31st ed. CLSI supplement M100 (ISBN 978-1-68440-104-8 [Print]; ISBN 978-1-68440-105-5 [Electronic]). Clinical and Laboratory Standards Institute, USA, 2021.
Document History